Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MPLT, LBRX, EVMN, HELP, INCY, and represent 66.20% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 3 stocks: ASND, HELP, CHYM.
- Started 2 new stock positions in ASND, CHYM.
- Reduced shares in these 3 stocks: Ascendis Pharma A S, OCS, BOLT.
- Sold out of its position in Ascendis Pharma A S.
- Nan Fung Group Holdings was a net buyer of stock by $3.6M.
- Nan Fung Group Holdings has $132M in assets under management (AUM), dropping by 8.43%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 25 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Maplight Therapeutics (MPLT) | 26.5 | $35M | 971k | 35.84 |
|
|
| Lb Pharmaceuticals Com Shs (LBRX) | 15.6 | $21M | 631k | 32.45 |
|
|
| Evommune Com Shs (EVMN) | 14.6 | $19M | 1.4M | 13.29 |
|
|
| Cybin Com New (HELP) | 5.0 | $6.5M | +114% | 987k | 6.61 |
|
| Incyte Corporation (INCY) | 4.6 | $6.1M | 54k | 113.36 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 4.1 | $5.5M | 49k | 111.03 |
|
|
| Beone Medicines Sponsored Ads (ONC) | 3.4 | $4.5M | 16k | 284.97 |
|
|
| Oculis Holding Ordinary Shares (OCS) | 3.2 | $4.2M | -14% | 301k | 13.87 |
|
| Ascendis Pharma A/s Ord Shs (ASND) | 2.8 | $3.6M | NEW | 14k | 266.72 |
|
| Revolution Medicines (RVMD) | 2.7 | $3.6M | 19k | 187.28 |
|
|
| Kymera Therapeutics (KYMR) | 2.7 | $3.5M | 31k | 114.67 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 2.3 | $3.0M | 5.7k | 536.95 |
|
|
| Celcuity (CELC) | 2.3 | $3.0M | 28k | 104.62 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 2.0 | $2.6M | 103k | 25.30 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 2.0 | $2.6M | 2.8k | 927.77 |
|
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 1.7 | $2.2M | 595k | 3.67 |
|
|
| Procore Technologies (PCOR) | 1.6 | $2.2M | 53k | 40.62 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 0.7 | $985k | 27k | 36.41 |
|
|
| Insmed Com Par $.01 (INSM) | 0.5 | $702k | 6.6k | 106.62 |
|
|
| Ishares Ethereum Tr SHS (ETHA) | 0.5 | $601k | 51k | 11.89 |
|
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.4 | $532k | 16k | 33.29 |
|
|
| Chime Finl Com Shs Cl A (CHYM) | 0.3 | $432k | NEW | 21k | 20.48 |
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.3 | $375k | 494k | 0.76 |
|
|
| Entrada Therapeutics (TRDA) | 0.3 | $361k | 49k | 7.36 |
|
|
| Bolt Biotherapeutics Com New (BOLT) | 0.0 | $19k | -82% | 5.0k | 3.85 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2026 Q2 filed Aug. 13, 2026
- Nan Fung Group Holdings 2026 Q1 filed May 14, 2026
- Nan Fung Group Holdings 2025 Q4 filed Feb. 13, 2026
- Nan Fung Group Holdings 2025 Q3 filed Nov. 13, 2025
- Nan Fung Group Holdings 2025 Q2 filed Aug. 13, 2025
- Nan Fung Group Holdings 2025 Q1 filed May 14, 2025
- Nan Fung Group Holdings 2024 Q4 filed Feb. 13, 2025
- Nan Fung Group Holdings 2024 Q3 filed Nov. 13, 2024
- Nan Fung Group Holdings 2024 Q2 filed Aug. 13, 2024
- Nan Fung Group Holdings 2024 Q1 filed May 14, 2024
- Nan Fung Group Holdings 2023 Q4 filed Feb. 13, 2024
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022